Diabetes Flashcards
sulphonylureas
inhibit the potassium ATP pump on beta cells > +insulin secretion
may cause weight gain
e.g. glibenclamide, glicazide
metformin
biguanide
increase the uptake of glucose by skeletal muscle
acts on the liver to inhibit glucneogenesis
25% develop GI side effects
pioglitazone
TF for genes involved in triglyceride storage. Stops deposition of lipids in non-adipose tissue, helping to reduce insulin resistance and the development of ALD.
works over a period of months
Side effects: increased long bone fractures, water retention and bladder cancer
DPP-IV inhibitors
DPP-IV normally degrades GLP-1 so inhibiting it allows GLP-1 to act for longer.
Well tolerated - weight neutral, oral tablet and provide a fairly stable glucose level
e.g. sitagliptin
GLP-1 agonists
GLP-1 normally secreted upon ingestion of food, causing:
beta: enhanced glucose-dependent secretion of insulin
alpha - decreased secretion of glucagon
liver - decreased hepatic glucose output
brain - promotes satiety and reduced appetite
stomach - slows gastric emptying
Drugs works very well and lead to weight loss as well.
Issue as they must be injected
e.g. exenatide
SGLT-2 inhibitors
Channel in the PCT that normally reabsorbs up to 90% of the glucose in the tubule.
have additional benefit of osmotic diuresis which can be beneficial in the context of hypertension.
can have issue where kidneys and pancreas cross-talk leading to release of glucagon, increasing chances of DKA developing
e.g. empaglifozin
what is whipple’s triad
Symptoms known or likely to be caused by hypoglycemia especially after fasting or heavy exercise (Autonomic or neuroglycopaenic symptoms)
A low plasma glucose measured at the time of the symptoms
Relief of symptoms when the glucose is raised to normal
name a rapidly acting insulin analogue
norvorapid
name a long-acting insulin analogue used as a basal insulin
lantus
how is hypoglycaemia defined in a diabetic on insulin therapy
<4.0 mmol/l of glucose
at what blood glucose level can you begin to see autonomic symptoms and what causes this
3.9 mmol/l - 3mmol/l (most occur at 3)
Caused by the release of the counter-regulatory hormones glucagon and adrenaline
at what blood glucose level will cognitive function begin to be disrupted
2.5-2.8 mmol/l.
at what blood glucose level will people begin to have seizures
<2 mmol/l of glucose
what are the diagnostic criteria for DKA
metabolic acidosis: Venous bicarbonate < 18mmol, H+ > 45 mEq/L, pH < 7.3
plasma glucose: >13.9 mmol/l
Urinary/plasma ketones: ≥2+ urinary / >3mmol/L
list the clinical features of DKA
- Osmotic Symptoms - Polydipsia and polyuria
- Weight Loss
- Breathlessness – Kussmaul respiration
- Abdominal pains, especially in children
- Leg cramps
- Nausea and vomiting
- Confusion